NCT02858310 E7 TCR T Cells for Human Papillomavirus-Associated Cancers Status COMPLETED Phase PHASE1/PHASE2
NCT02855359 Denintuzumab Mafodotin (SGN-CD19A) Combined With RCHOP or RCHP Versus RCHOP Alone in Diffuse Large B-Cell Lymphoma or Follicular Lymphoma Status TERMINATED Phase PHASE2
NCT02853318 Pembrolizumab, Bevacizumab, and Cyclophosphamide in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Status COMPLETED Phase PHASE2
NCT02846428 To Evaluate the Efficacy and Safety of Capecitabine Prior to Surgery in Women With Breast Cancer Status COMPLETED Phase PHASE2
NCT02845999 Allogenic Immunotherapy Based on Natural Killer (NK) Cell Adoptive Transfer in Metastatic Gastrointestinal Carcinoma Treated With Cetuximab Status COMPLETED Phase PHASE1
NCT02845596 Unrelated Donor Transplant Versus Immune Therapy in Pediatric Severe Aplastic Anemia Status COMPLETED Phase NA
NCT02844062 Pilot Study of Autologous Anti-EGFRvIII CAR T Cells in Recurrent Glioblastoma Multiforme Status UNKNOWN Phase PHASE1
NCT02833805 NMA Haplo or MUD BMT for Newly Diagnosed Severe Aplastic Anemia Status COMPLETED Phase PHASE2
NCT02830724 Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers Status RECRUITING Phase PHASE1/PHASE2
NCT02828592 Haploidentical Bone Marrow Transplant With Post-Transplant Cyclophosphamide for Patients With Severe Aplastic Anemia Status RECRUITING Phase PHASE2
NCT02828358 Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement Status COMPLETED Phase PHASE2
NCT02813135 European Proof-of-Concept Therapeutic Stratification Trial of Molecular Anomalies in Relapsed or Refractory Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT02809573 Clinical Trial of Chidamide Combined With CHOP in Peripheral T-cell Lymphoma Patients Status COMPLETED Phase PHASE1
NCT02806375 PTCy and Ruxolitinib GVHD Prophylaxis in Myelofibrosis Status COMPLETED Phase PHASE1/PHASE2
NCT02797717 Treatment for Classical Hodgkin Lymphoma in Children and Adolescents Status RECRUITING Phase NA
NCT02793856 PD-1 Knockout Engineered T Cells for Metastatic Non-small Cell Lung Cancer Status COMPLETED Phase PHASE1
NCT02790515 Provision of TCRγδ T Cells and Memory T Cells Plus Selected Use of Blinatumomab in Naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies Relapsed or Refractory Despite Prior Transplantation Status ACTIVE_NOT_RECRUITING Phase PHASE2